68 Preventive Care Adherence and Associated Factors in a National Sample of Hematopoietic Cell Transplantation (HCT) Survivors Recruited for an Online Randomized Controlled Trial (RCT)

Track: BMT Tandem "Scientific" Meeting
Saturday, February 14, 2015, 4:45 PM-6:45 PM
Seaport Ballroom ABC (Manchester Grand Hyatt)
Jean C. Yi, PhD , Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
Samantha B. Artherholt, PhD , Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA
Eun-Ju Lee, BS , Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
Susan Stewart , Blood & Marrow Transplant Information Network, Highland Park, IL
Mary E. D. Flowers, MD , Department of Medicine, University of Washington School of Medicine, Seattle, WA
Karen L. Syrjala, PhD , Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Introduction: HCT survivors require long-term surveillance and preventive care to reduce the late effects of treatment. We examined demographic, treatment and psychosocial factors associated with preventive care adherence (PCA) in a national sample of survivors recruited for an online RCT.

Method: Four email invitations to participate were sent to HCT survivors on the BMT InfoNet listserve, a patient resource and advocacy site. Eligibility criteria included ≥18 years old, more than two years post-HCT, without a recurrence or second cancer in the prior two years, able to communicate in English, and with internet and email access. Measures were the Short Form-36 physical component scale (PCS), Symptom Checklist-90-R depression, Cancer and Treatment Distress, Katz Comorbidity Index, Confidence in Survivorship Information (CSI) about recommended PCA tests for HCT survivors, and Barriers to PCA. Multivariate logistic regression was used to analyze factors associated with not meeting PCA criteria for at least 75% of 15 exams.

Results: Of 493 registered survivors, 395 (80%) were eligible for analysis.  Participants were from the U.S. (93%, N=368) and 12 other countries, treated at 142 centers, largely Caucasian and non-Hispanic (94%), on average 9 years post-HCT (SD=6, range 2-33); 67% received allogeneic HCT, 38% reported a history of moderate to severe chronic graft versus host disease (cGVHD). The percentage of survivors who did not meet recommended criteria on 75% of the 15 potential PCA tests was 37% (N=147). Age, race and ethnicity, years post-transplant, comorbidities, depression and distress were not associated with PCA (P's >.05). Table 1 indicates the odds ratios and confidence intervals for factors associated with PCA in the final model including: gender, cGVHD history, SF-36 PCS T scores, CSI, and 3 types of barriers: financial, concerns about side effects, and time constraints.

Discussion: Over a third of HCT long-term survivors interested in an online RCT did not meet PCA recommendations, indicating need for improved dissemination of preventive guidelines. Those needing targeted approaches to improve PCA include males, those doing better in physical function and lack of cGVHD history, and those with definable barriers to health care.

Table 1. Predictors of Preventive Care Adherence (N=387 in Logistic Regression)

OR (95%CI)

P value

Gender

   Male

   Female

referent
4.64 (2.78-7.76)

<.001

cGVHD History

   None-mild
   Moderate-severe

referent
2.29 (1.37-3.85)

.002

Financial Barriers

   No

   Yes

referent
2.30 (1.08-4.90)

.03

Side Effects Barriers

   No

   Yes

referent
2.28 (1.15-4.52)

.02

Time Constraints Barriers

   No

   Yes

referent
2.25 (1.12-4.52)

.02

SF-36 Physical Component T score

1.03 (1.01-1.06)

.01

Confidence in Survivorship Information

0.36 (.21-.60)

<.001


Disclosures:
Nothing To Disclose
<< Previous Presentation | Next Presentation